In Vitro 31P NMR Spectroscopy Detects Altered Phospholipid Metabolism in Alzheimer's Disease

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques

Volumn 13, Issue S4, 1986, Pages 535-539

  Miatto, Orietta ^a   Gonzalez, R Gilberto ^b   Buonanno, Ferdinando ^a   Growdon, John H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOISOTOPE; DIAGNOSTIC AGENT; PHOSPHOLIPID; PHOSPHORUS;

ALZHEIMER DISEASE; AUTOPSY; CENTRAL NERVOUS SYSTEM; HUMAN; HUMAN CELL; NUCLEAR MAGNETIC RESONANCE; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; ARTICLE; BRAIN; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SPECTROSCOPY;

ALZHEIMER DISEASE; BRAIN; HUMAN; MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHOLIPIDS; PHOSPHORUS; SPECTRUM ANALYSIS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0022931005     PISSN: 03171671     EISSN: 20570155     Source Type: Journal    
DOI: 10.1017/S0317167100037276     Document Type: Article

References (31)

1. Differentiating senile dementia of Alzheimer type and multi-infarct dementia by proton NMR imaging, J.A. Besson, F.M. Corrigan, E.I. Foreman, Lancet, 1983, 2, 789
2. Nuclear magnetic resonance (NMR). II Imaging in dementia, J.A. Besson, F.M. Corrigan, E.I. Foreman, Brit J Psychiat, 1985, 146, 31-35
3. Proton NMR parameters and dementia, J.A. Besson, F.M. Corrigan, E.I. Foreman, Progress in Nuclear Medicine, 1984, 8, 94-99
4. Cognitive evaluation following NMR imaging of the brain, J.A. Besson, E.I. Foreman, L.M. Eastwood, J Neurol Neurosurg Psychiatr, 1984, 47, 314-316
5. Nuclear magnetic resonance observations in alcoholic cerebral disorder and the role of vasopressin, J.A. Besson, A.I. Glen, A. MacDonald, Lancet, 1981, 2, 923-924
6. MR imaging of the aging brain: patchy white-matter lesions and dementia, M. Brant-Zawadzki, G. Fein, C. Van-Dyke, Am J. Neurol Res, 1985, 6-5, 675-682
7. MRI and the study of aphasia, L.D. DeWitt, A.H. Grek, F.S. Buonanno, Neurology, 1985, 35, 861-865
8. Cerebral NMR and CT imaging in dementia, T. Erkinjuntti, J.T. Sipponen, M. Iivanainen, J Computer Assisted Tomography, 1984, 8, 614-618
9. Subcortical arteriosclerotic encephalopathy (Binswanger’s disease). Computed tomographic, nuclear magnetic resonance, and clinical correlations, W.R. Kinkel, L. Jacobs, I. Polachini, Arch Neurol, 1985, 42, 951-959
10. Cerebral MR and CT imaging in Creutzfeldt-Jakob disease, J. Kovanen, T. Erkinjuntti, M. Iivanainen, J Computer Assisted Tomography, 1985, 9-1, 125-128
11. Comparison of magnetic resonance (MR) and x-ray computed tomography (CT) in dementia. Neurology, K. Johnson, F. Buonanno, K. Davis, 1986, 36, Supplement 1, 265
12. Diagnostic methods in Alzheimer’s disease: magnetic resonance brain imaging and CSF neurotransmitter markers, J.H. Growdon, S. Corkin, F. Buonanno, Alzheimer’s and Parkinson’s Disease. Strategies in Research and Development, 1986, 191-204, In: Fisher A, Hanin I, Lachman C. eds., New York: Plenum Press
13. 31-P nuclear magnetic resonance analysis of brain: the perchloric acid extract spectrum, T. Glonek, S.H. Kopp, E. Kot, J Neurochem, 1982, 39, 1210-1219
14. Analysis of phosphate metabolites, the intracellular pH and the state of adenosine triphosphate in intact muscle by phosphorus nuclear magnetic spectroscopy, C.T. Burt, R. Glonek, R. Barany, J Biol Chem, 1982, 251, 2584
15. Lipids of the nervous system: changes with age, species variation, lipid class relationships, and comparison of brain to other organs, G. Rouser, A. Yamamoto, G. Kritchevsky, Chemistry and Brain Development, 1971, 91-109, In: Paoletta R, Davison AN, eds., New York: Plenum Press
16. Phospholipid methylation and biological signal transmission, F. Hirata, J. Axelrod, Science, 1980, 209, 1082-1090
17. Choline and cholinergic neurons, J.K. Blusztajn, R.H. Wurtman, Science, 1983, 221, 614-620
18. Effect of hypoglycemic encephalopathy upon amino acids, high-energy phosphates, and pH in the rat brain in vivo: detection by sequential 1H and 31P NMR spectroscopy, K.L. Behar, J.A., denHollander, O.A.C. Petroff, J Neurochem, 1985, 44, 1045-1055
19. M.R. Bendall, Biochemical Magnetic Resonance, 1984, 99, In: James TL, Margulis AR, eds., San Francisco CA. Radiology Research and Education Foundation
20. In vivo solvent surpressed localized hydrogen nuclear magnetic resonance spectroscopy: a window to metabolism?, P.A. Bottomley, W.A. Edelstein, T.H. Foster, Proceedings of National Academy of Sciences USA, 1985, 82, 2148-2152
21. Cerebral energy metabolism in rats studied by phosphorus nuclear magnetic resonance using surface coils, P.A. Bottomley, K. Kogure, R. Namon, Magnetic Resonance Imaging, 1982, 1, 81-85
22. Phosphoethanolamine is a major constituent of phosphomonoester peak detected by 31 NMR in newborn brain, D.P. Brenton, P.J. Garrod, S. Krywawych, Lancet, 1985, 1, 115
23. Nuclear Magnetic Resonance and Its Application to Living Systems, D.G. Gadian, D.J. Tayler, Molecular Biological Medicine, 1982, 1, 77, Bore PJ, Syles P, et al, eds. Oxford. Oxford Univ Press
24. Phosphorylethanolamine —the major constituent of the phosphomonoester peak observed by 31P NMR on developing dog brain, L. Gyulai, L. Bolinger, J.S. Leigh, Jr., FEBS Letters, 1984, 178, 137-142
25. Clinical aspects on 31P NMR spectroscopy, G.K. Radda, P.J. Bore, B. Rajagopalan, Brit Med Bull, 1984, 40, 155-159
26. Bioenergetics of intact human muscle: a31P nuclear magnetic resonance study, D.J. Taylor, P.J. Bore, P. Styles, Molecular Biological Medicine, 1983, 1, 77-94
27. 31-P changes in Alzheimer’s and Huntington’s disease brain, J.W. Pettegrew, N.J. Minshew, N.M. Cohen, Neurology, 1984, 34, 281
28. A hypothesis: noncyclic phosphodiesters may play a role in membrane control, C.T. Burt, H.J.J. Ribolow, Biochem Med, 1984, 31, 21-30
29. A new approach to metabolite compartmentation in muscle, P.J. Seeley, S.J.W. Busby, D.G. Gadian, Trans Biochem Soc, 1976, 4, 62-64
30. Reduced phospholipase Dactivity in brain tissue samples from Alzheimer’s disease patients, J.N. Kanfer, H. Hattori, D. Oribel, Ann Neurol, 1986, 20, 265-267
31. Increased glycerol-3-phos-phorylcholine in post-mortem Alzheimer’s brain, M. Barany, Y.C. Chang, C. Arus, Lancet, 1985, 1, 517